Operations

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.

Penn Medicine's Anna Schoenbaum says the HIMSS Nursing Innovation Advisory Workgroup, which she co-chairs, has developed AI toolkits and customizable teaching slides to help leaders understand AI's complexity, costs and impact.

Christopher McGhee says that, along with the acquisition, Current Health will have a "return to scrappiness and that startup spirit."

Nicole Rogas, RevSpring president, says health systems can improve the billing experience and collect more revenue by using AI and data analytics to create personalized messages delivered via patients' preferred contact methods.

The company will use the funds to invest in research and development and to scale its voice AI platform.   

AI tools can personalize patients' searches for providers, but Kyruus Health's Gen Conlin believes nurse informaticists' ability to ensure tool accessibility and accuracy are vital to ensuring patients find the right care.

Eversana senior vice president of health innovation, Alberta Spreafico, discusses the company's collaboration with the Digital Therapeutics Alliance to analyze frameworks and map reimbursement pathways in Europe for digital health adoption.

In response to a new price cap law in Indiana, Hal Andrews, CEO of Trilliant Health, says once a state legislature is allowed to determine maximum reimbursement, hospitals are subject to that being changed any time the legislature gets together.  

Edward Marx, CEO of Marx Advisory, recommends that healthcare leaders looking to drive innovation in their organizations become innovative themselves by bringing their C-suite to meet with and learn from partners.

Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.